share_log

RBC Raises Price Target on WAVE Life Sciences to $7 From $5, Keeps Sector Perform Rating, Speculative Risk

RBC Raises Price Target on WAVE Life Sciences to $7 From $5, Keeps Sector Perform Rating, Speculative Risk

RBC將wave life sciences的目標股價從5美元上調至7美元,保持板塊表現評級,具有投機風險
MT Newswires ·  10/04 19:30  · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論